loadpatents
Patent applications and USPTO patent grants for BHATT; Padmanabh P..The latest application filed is for "methods for producing viloxazine salts and novel polymorphs thereof".
Patent | Date |
---|---|
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20220024885 - LIANG; Likan ;   et al. | 2022-01-27 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 11,166,960 - Bhatt , et al. November 9, 2 | 2021-11-09 |
Stabilized Formulations Of Cns Compounds App 20210322429 - Chang; Rong-Kun ;   et al. | 2021-10-21 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20210308142 - BHATT; Padmanabh P. ;   et al. | 2021-10-07 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20210236510 - BHATT; Padmanabh P. ;   et al. | 2021-08-05 |
Stabilized formulations of CNS compounds Grant 11,077,114 - Chang , et al. August 3, 2 | 2021-08-03 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20210038613 - BHATT; Padmanabh P. ;   et al. | 2021-02-11 |
Osmotic Drug Delivery System App 20200261371 - Kidane; Argaw ;   et al. | 2020-08-20 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20190381063 - BHATT; Padmanabh P. ;   et al. | 2019-12-19 |
Osmotic Drug Delivery System App 20190336450 - Kidane; Argaw ;   et al. | 2019-11-07 |
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20190300492 - LIANG; Likan ;   et al. | 2019-10-03 |
Formulations Of Viloxazine App 20190201407 - VIEIRA; Michael L. ;   et al. | 2019-07-04 |
Sustained-release formulations of topiramate Grant 10,314,790 - Liang , et al. | 2019-06-11 |
Formulations of viloxazine Grant 10,265,319 - Vieira , et al. | 2019-04-23 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 10,220,042 - Bhatt , et al. | 2019-03-05 |
Stabilized Formulations Of Cns Compounds App 20190060323 - CHANG; Rong-Kun ;   et al. | 2019-02-28 |
Methods for producing viloxazine salts and novel polymorphs thereof Grant 10,160,733 - Liang , et al. Dec | 2018-12-25 |
Osmotic drug delivery system Grant 10,154,965 - Kidane , et al. Dec | 2018-12-18 |
Stabilized formulations of CNS compounds Grant 10,149,853 - Chang , et al. Dec | 2018-12-11 |
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20180265482 - LIANG; Likan ;   et al. | 2018-09-20 |
Methods for producing viloxazine salts and novel polymorphs thereof Grant 10,005,743 - Liang , et al. June 26, 2 | 2018-06-26 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20180098996 - BHATT; Padmanabh P. ;   et al. | 2018-04-12 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 9,855,278 - Bhatt , et al. January 2, 2 | 2018-01-02 |
Sustained-release Formulations Of Topiramate App 20170266121 - LIANG; Likan ;   et al. | 2017-09-21 |
Formulations Of Viloxazine App 20170258801 - VIEIRA; Michael L. ;   et al. | 2017-09-14 |
Formulations of viloxazine Grant 9,662,338 - Vieira , et al. May 30, 2 | 2017-05-30 |
Sustained-release formulations of topiramate Grant 9,622,983 - Liang , et al. April 18, 2 | 2017-04-18 |
Formulations of viloxazine Grant 9,603,853 - Vieira , et al. March 28, 2 | 2017-03-28 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20170056411 - BHATT; Padmanabh P. ;   et al. | 2017-03-02 |
Sustained-release formulations of topiramate Grant 9,555,004 - Liang , et al. January 31, 2 | 2017-01-31 |
Sustained-release formulations of topiramate Grant 9,549,940 - Liang , et al. January 24, 2 | 2017-01-24 |
Sustained-release Formulations Of Topiramate App 20160375048 - LIANG; Likan ;   et al. | 2016-12-29 |
Sustained-release Formulations Of Topiramate App 20160375047 - LIANG; Likan ;   et al. | 2016-12-29 |
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20160304475 - LIANG; Likan ;   et al. | 2016-10-20 |
Formulations Of Viloxazine App 20160279136 - VIEIRA; Michael L. ;   et al. | 2016-09-29 |
Osmotic Drug Delivery System App 20160263042 - Kidane; Argaw ;   et al. | 2016-09-15 |
Formulations Of Viloxazine App 20160256465 - VIEIRA; Michael L. ;   et al. | 2016-09-08 |
Viloxazine compositions Grant 9,434,703 - Liang , et al. September 6, 2 | 2016-09-06 |
Methods for producing viloxazine salts and novel polymorphs thereof Grant 9,403,783 - Liang , et al. August 2, 2 | 2016-08-02 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 9,370,525 - Bhatt , et al. June 21, 2 | 2016-06-21 |
Formulations of viloxazine Grant 9,358,204 - Vieira , et al. June 7, 2 | 2016-06-07 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 9,351,975 - Bhatt , et al. May 31, 2 | 2016-05-31 |
Osmotic Drug Delivery System App 20160030355 - Kidane; Argaw ;   et al. | 2016-02-04 |
Sustained-release Formulations Of Topiramate App 20160022596 - Liang; Likan ;   et al. | 2016-01-28 |
Formulations Of Mazindol App 20160008285 - Kidane; Argaw ;   et al. | 2016-01-14 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20150359748 - Bhatt; Padmanabh P. ;   et al. | 2015-12-17 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20150359800 - Bhatt; Padmanabh P. ;   et al. | 2015-12-17 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 9,119,791 - Bhatt , et al. September 1, 2 | 2015-09-01 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 9,119,792 - Bhatt , et al. September 1, 2 | 2015-09-01 |
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20150126735 - Liang; Likan ;   et al. | 2015-05-07 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20150099739 - Bhatt; Padmanabh P. ;   et al. | 2015-04-09 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20150094301 - Bhatt; Padmanabh P. ;   et al. | 2015-04-02 |
Sustained-release formulations of topiramate Grant 8,992,989 - Liang , et al. March 31, 2 | 2015-03-31 |
Stabilized Formulations Of Cns Compounds App 20150086629 - Chang; Rong-Kun ;   et al. | 2015-03-26 |
Enhanced Immediate Release Formulations Of Topiramate App 20150024055 - Liang; Likan ;   et al. | 2015-01-22 |
Sustained-release Formulations Of Topiramate App 20150017249 - Liang; Likan ;   et al. | 2015-01-15 |
Sustained-release formulations of topiramate Grant 8,889,191 - Liang , et al. November 18, 2 | 2014-11-18 |
Sustained-release formulations of topiramate Grant 8,877,248 - Liang , et al. November 4, 2 | 2014-11-04 |
Sustained-release Formulations Of Topiramate App 20140322343 - Liang; Likan ;   et al. | 2014-10-30 |
Osmotic Drug Delivery System App 20140303252 - Kidane; Argaw ;   et al. | 2014-10-09 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 8,821,930 - Bhatt , et al. September 2, 2 | 2014-09-02 |
Osmotic drug delivery system Grant 8,747,897 - Kidane , et al. June 10, 2 | 2014-06-10 |
Stabilized formulations of CNS compounds Grant 8,748,472 - Chang , et al. June 10, 2 | 2014-06-10 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20140100219 - Bhatt; Padmanabh P. ;   et al. | 2014-04-10 |
Sustained-release formulations of topiramate Grant 8,663,683 - Liang , et al. March 4, 2 | 2014-03-04 |
Controlled Release Compositions Of Gamma-hydroxybutyrate App 20140037745 - Liang; Likan ;   et al. | 2014-02-06 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 8,617,600 - Bhatt , et al. December 31, 2 | 2013-12-31 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 08617600 - | 2013-12-31 |
Controlled release compositions of gamma-hydroxybutyrate Grant 8,598,191 - Liang , et al. December 3, 2 | 2013-12-03 |
Formulations Of Viloxazine App 20130202661 - Vieira; Michael L. ;   et al. | 2013-08-08 |
Formulations Of Mazindol App 20130011483 - Kidane; Argaw ;   et al. | 2013-01-10 |
Sustained-release Formulations Of Topiramate App 20120321708 - Liang; Likan ;   et al. | 2012-12-20 |
Sustained-release formulations of topiramate Grant 8,298,576 - Liang , et al. October 30, 2 | 2012-10-30 |
Sustained-release formulations of topiramate Grant 8,298,580 - Liang , et al. October 30, 2 | 2012-10-30 |
Controlled Release Compositions Of Gamma-hydroxybutyrate App 20120231085 - Liang; Likan ;   et al. | 2012-09-13 |
Modified Release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20120232060 - Bhatt; Padmanabh P. ;   et al. | 2012-09-13 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 8,211,464 - Bhatt , et al. July 3, 2 | 2012-07-03 |
Controlled release compositions of gamma-hydroxybutyrate Grant 8,193,211 - Liang , et al. June 5, 2 | 2012-06-05 |
Modified release preparations containing oxcarbazepine and derivatives thereof App 20110301147 - Bhatt; Padmanabh P. ;   et al. | 2011-12-08 |
Sustained-release formulations of topiramate App 20110287103 - Liang; Likan ;   et al. | 2011-11-24 |
Sustained-release formulations of topiramate App 20110287099 - Liang; Likan ;   et al. | 2011-11-24 |
Methods For Producing Viloxazine Salts And Novel Polymorphs Thereof App 20110251198 - Liang; Likan ;   et al. | 2011-10-13 |
Stabilized Formulations Of Cns Compounds App 20110244042 - CHANG; Rong-Kun ;   et al. | 2011-10-06 |
Modified release preparations containing oxcarbazepine and derivatives thereof Grant 8,017,149 - Bhatt , et al. September 13, 2 | 2011-09-13 |
Method of treating seizures using modified release formulations of oxcarbazepine Grant 7,910,131 - Bhatt , et al. March 22, 2 | 2011-03-22 |
Formulations of desvenlafaxine App 20100209489 - Liang; Likan ;   et al. | 2010-08-19 |
Modified-release preparations containing oxcarbazepine and derivatives thereof Grant 7,722,898 - Bhatt , et al. May 25, 2 | 2010-05-25 |
Controlled Release Formulations Of Pramipexole App 20090304794 - Vieira; Michael L. ;   et al. | 2009-12-10 |
Controlled Release Formulations Of Alprazolam App 20090280176 - Vieira; Michael L. ;   et al. | 2009-11-12 |
Osmotic delivery of therapeutic compounds by solubility enhancement Grant 7,611,728 - Kidane , et al. November 3, 2 | 2009-11-03 |
Enhanced Formulations Of Lamotrigine App 20090022789 - KIDANE; Argaw ;   et al. | 2009-01-22 |
Modified release preparations containing oxcarbazepine and derivatives thereof App 20090005360 - Bhatt; Padmanabh P. ;   et al. | 2009-01-01 |
Modified release preparations containing oxcarbazepine and derivatives thereof App 20090004263 - Bhatt; Padmanabh P. ;   et al. | 2009-01-01 |
Enhanced immediate release formulations of topiramate App 20080131501 - Liang; Likan ;   et al. | 2008-06-05 |
Sustained-release Formulations Of Topiramate App 20080118557 - Liang; Likan ;   et al. | 2008-05-22 |
Modified-release Preparations Containing Oxcarbazepine And Derivatives Thereof App 20070254033 - Bhatt; Padmanabh P. ;   et al. | 2007-11-01 |
Osmotic drug delivery system App 20070254032 - Kidane; Argaw ;   et al. | 2007-11-01 |
Orally administrable extended release pellet and tablet formulations of a highly water soluble compound App 20070134315 - Viera; Michael L. ;   et al. | 2007-06-14 |
Controlled release compositions of gamma-hydroxybutyrate App 20060210630 - Liang; Likan ;   et al. | 2006-09-21 |
Osmotic delivery of therapeutic compounds by solubility enhancement App 20050053653 - Kidane, Argaw ;   et al. | 2005-03-10 |
Methods for providing effective reboxetine therapy with once-a-day dosing Grant 6,630,165 - Seroff , et al. October 7, 2 | 2003-10-07 |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing App 20020146453 - Seroff, Sylvia L. ;   et al. | 2002-10-10 |
SEC | 0001539215 | Bhatt Padmanabh P. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.